Angiodynamics (ANGO) Income from Discontinued Operations (2017 - 2019)

Angiodynamics (ANGO) has reported Income from Discontinued Operations for 3 consecutive years, with $56.1 million the latest figure, recorded in Q2 2019.

• For the quarter ending Q2 2019, Income from Discontinued Operations rose 536.93% year-over-year to $56.1 million; the trailing twelve-month figure through Feb 2020 stood at $56.1 million (up 122.89% YoY), and the FY2019 full-year result was $72.5 million, up 221.27% from the prior year.
• Income from Discontinued Operations rose to $56.1 million in Q2 2019 per ANGO's latest filing, from $5.4 million in the prior quarter.
• Across five years, Income from Discontinued Operations topped out at $56.1 million in Q2 2019 and bottomed at $4.1 million in Q1 2018.
• Historically, Income from Discontinued Operations has averaged $11.9 million across 3 years, with a median of $5.3 million in 2018.
• The sharpest annual moves came in 2018 and 2019: Income from Discontinued Operations climbed 5.27% in 2018, then surged 536.93% in 2019.
• Over 3 years, Income from Discontinued Operations stood at $4.7 million in 2017, then gained by 22.84% to $5.7 million in 2018, then surged by 879.92% to $56.1 million in 2019.
• According to Business Quant data, Income from Discontinued Operations over the past three periods registered $56.1 million, $5.4 million, and $5.7 million for Q2 2019, Q1 2019, and Q4 2018 respectively.